title: Implementation of a recombinant factor IX Fc fusion protein extended-infusion desensitization protocol.
authors.affiliation: Department of Pharmacy, Huntsman Cancer Institute, Salt Lake City, UT, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Clough
authors.affiliation: Department of Pharmacy, Huntsman Cancer Institute, Salt Lake City, UT, USA.|Department of Pharmacotherapy, College of Pharmacy, The University of Utah, Salt Lake City, UT, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Gilreath
authors.affiliation: Department of Pharmacy, Huntsman Cancer Institute, Salt Lake City, UT, USA.
authors.forename: J P
authors.identifier: 0000-0003-4038-7951
authors.initials: JP
authors.lastname: McPherson
authors.affiliation: Department of Pharmacy, Huntsman Cancer Institute, Salt Lake City, UT, USA.
authors.forename: N C
authors.initials: NC
authors.lastname: Link
authors.affiliation: Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT, USA.
authors.forename: G M
authors.initials: GM
authors.lastname: Rodgers
authors.affiliation: Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT, USA.
authors.forename: D
authors.initials: D
authors.lastname: Nance
mesh_terms: D000328:Adult; D004334:Drug Administration Schedule; D005164:Factor IX / Q000008:administration & dosage* / Q000627:therapeutic use*; D002836:Hemophilia B / Q000188:drug therapy; D006801:Humans; D007141:Immunoglobulin Fc Fragments / Q000008:administration & dosage* / Q000627:therapeutic use*; D007260:Infusion Pumps; D008297:Male; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage* / Q000627:therapeutic use*
chemical_list: D007141:Immunoglobulin Fc Fragments; D011993:Recombinant Fusion Proteins; C000599709:factor IX Fc fusion protein; D005164:Factor IX